Skip to main content
SpringerLink
Log in

Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Objectives

Oslo, the capital of Norway, has a high prevalence of multiple sclerosis (MS). In recent decades there has been substantial immigration to Oslo from Asia, the Middle East and Africa. The aim of the study was to estimate the prevalence of MS among non-Western immigrants living in Oslo, adjusted for duration of residence.

Methods

Data were obtained from the MS registry at Ullevål University Hospital. The prevalence of MS was adjusted for ethnicity, age and duration of residence in Norway.

Results

A total of 786 definite MS patients were alive and resident in Oslo on 31 December 2005, yielding a crude prevalence of 148/105. Twentyseven patients were of non-Western origin: Middle East 14, Asia 9, Africa 4. The non-Western patients' mean age at migration was 20. The crude prevalence (95 % CI) of MS patients was 170/105 (159–182) for the Norwegian/Western, 85/105 (50–143) for the Middle East, 21/105 (11–41) for the Asian, and 20/105 (7–53) for the African cohorts. The high MS prevalence in the Middle East cohort and the low prevalence among Asian/African immigrants were also pronounced after adjustment for age and duration of residence.

Conclusions

The Middle East immigrants had a markedly higher prevalence of MS despite a shorter duration of residence than other non-Western patients. These findings suggest that people from the Middle East have a greater genetic disposition for MS. Furthermore, the high age at migration among the non-Western immigrants indicates that possible environmental factors affecting MS risk may also act on adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. (2005) McAlpine's multiple sclerosis. Churchill Livingstone Elsevier, Philadelphia

  2. Al-Araji A, Mohammed AI (2005) Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? J Neurol Sci 234:67–71

    Article  PubMed  Google Scholar 

  3. al-Din AS, El-Khateeb M, Kurdi A, Mubaidin A, Wriekat A, al-Shehab A, Khalil RW (1995) Multiple sclerosis in Arabs in Jordan. J Neurol Sci 131:144–149

    Article  PubMed  CAS  Google Scholar 

  4. al-Din AS, Khogali M, Poser CM, al- Nassar KE, Shakir R, Hussain J, Behbahani K, Chadha G (1990) Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians. J Neurol Sci 100:137–141

    Article  PubMed  CAS  Google Scholar 

  5. Alshubaili AF, Alramzy K, Ayyad YM, Gerish Y (2005) Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence. Eur Neurol 53:125–131

    Article  PubMed  CAS  Google Scholar 

  6. Alstadhaug KB, Olavsen J, Salvesen R (2005) [Occurrence of multiple sclerosis in Nordland, 1970–1999]. Tidsskr Nor Laegeforen 125:431–433

    PubMed  Google Scholar 

  7. Alter M, Kahana E, Zilber N, Miller A (2006) Multiple sclerosis frequency in Israel's diverse populations. Neurology 66:1061–1066

    Article  PubMed  Google Scholar 

  8. Alter M, Leibowitz U, Speer J (1966) Risk of multiple sclerosis related to age at immigration to Israel. Arch Neurol 15:234–237

    PubMed  CAS  Google Scholar 

  9. Amirzargar A, Mytilineos J, Farjadian S, Doroudchi M, Scherer S, Opelz G, Ghaderi A (2001) Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 62:1234–1238

    Article  PubMed  CAS  Google Scholar 

  10. Cabre P, Signate A, Olindo S, Merle H, Caparros-Lefebvre D, Bera O, Smadja D (2005) Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 128:2899–2910

    Article  PubMed  CAS  Google Scholar 

  11. Celius EG, Vandvik B (2001) Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 8:463–469

    Article  PubMed  CAS  Google Scholar 

  12. Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R (2004) Multiple sclerosis in Nord-Trondelag County, Norway: a prevalence and incidence study. Acta Neurol Scand 109:378–384

    Article  PubMed  CAS  Google Scholar 

  13. Dean G (1967) Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. Br Med J 2:724–730

    PubMed  CAS  Google Scholar 

  14. Dean G, Elian M (1997) Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 63:565–568

    PubMed  CAS  Google Scholar 

  15. Dean G, Kurtzke JF (1971) On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J 3:725–729

    Article  PubMed  CAS  Google Scholar 

  16. Dean G, McLoughlin H, Brady R, Adelstein AM, Tallett-Williams J (1976) Multiple sclerosis among immigrants in Greater London. Br Med J 1:861–864

    PubMed  CAS  Google Scholar 

  17. Detels R, Visscher BR, Haile RW, Malmgren RM, Dudley JP, Coulson AH (1978) Multiple sclerosis and age at migration. Am J Epidemiol 108: 386–393

    PubMed  CAS  Google Scholar 

  18. El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y (2006) Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 253(9):1210–1216

    Article  PubMed  Google Scholar 

  19. Elian M, Nightingale S, Dean G (1990) Multiple sclerosis among United Kingdom- born children of immigrants from the Indian subcontinent, Africa and the West Indies. [see comment]. J Neurol Neurosurg Psychiatry 53:906–911

    PubMed  CAS  Google Scholar 

  20. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F (2006) Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 27:39–44

    Article  PubMed  Google Scholar 

  21. Gale CR, Martyn CN (1995) Migrant studies in multiple sclerosis. Prog Neurobiol 47:425–448

    Article  PubMed  CAS  Google Scholar 

  22. Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM (2006) A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 66:182–186

    Article  PubMed  CAS  Google Scholar 

  23. Hammond SR, English DR, McLeod JG (2000) The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 123 (Pt 5):968–974

    Article  PubMed  Google Scholar 

  24. Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sorensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A (2004) Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63:237–247

    Article  PubMed  CAS  Google Scholar 

  25. Hillert J (1994) Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 36 (Suppl):S15-S17

    Article  PubMed  Google Scholar 

  26. Kahana E, Zilber N, Abramson JH, Biton V, Leibowitz Y, Abramsky O (1994) Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated. J Neurol 241:341–346

    Article  PubMed  CAS  Google Scholar 

  27. Kalanie H, Kamgooyan M, Sadeghian H, Kalanie AR (2000) Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran. Mult Scler 6:317–319

    PubMed  CAS  Google Scholar 

  28. Kankonkar S, Jeyanti G, Singhal BS, Shankarkumar U (2003) Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India. Hum Immunol 64:478–482

    Article  PubMed  CAS  Google Scholar 

  29. Karni A, Kahana E, Zilber N, Abramsky O, Alter M, Karussis D (2003) The frequency of multiple sclerosis in Jewish and Arab populations in greater Jerusalem. Neuroepidemiology 22:82–86

    Article  PubMed  Google Scholar 

  30. Kira J (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2:117–127

    Article  PubMed  Google Scholar 

  31. Kleinbaum DG (1982) Epidemiologic research: principles and quantitative methods.Van Nostrand Reinhold, New York

    Google Scholar 

  32. Kurtzke JF, Delasnerie-Laupretre N, Wallin MT (1998) Multiple sclerosis in North African migrants to France. Acta Neurologica Scandinavica 98:302–309

    Article  PubMed  CAS  Google Scholar 

  33. Lofthus E (1998) Immigrants in Norway: a summary of findings. Statistisk sentralbyrå, Oslo

    Google Scholar 

  34. Marrie RA (2004) Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3:709–718

    Article  PubMed  Google Scholar 

  35. Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser SL (2004) Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 74:160–167

    Article  PubMed  CAS  Google Scholar 

  36. Poser CM, Paty DW, Scheinberg L, Mc- Donald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231

    Article  PubMed  CAS  Google Scholar 

  37. Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117–139

    Article  PubMed  CAS  Google Scholar 

  38. Saida T (2004) First Regional MS Forum Meeting raises MS awareness and highlights questions. The MS Forum Pan-Asian Conference, 912 October 2003, Bangkok, Thailand. Int MS J 11:32–33

    PubMed  Google Scholar 

  39. The Municipality of Oslo.Development and improvement authority. (2005) [Statistical Yearbook of Oslo 2005 (online)]. The Municipality of Oslo.Development and improvement authority, Oslo

  40. Wadia NH, Bhatia K (1990) Multiple sclerosis is prevalent in the Zoroastrians (Parsis) of India. Ann Neurol 28:177–179

    Article  PubMed  CAS  Google Scholar 

  41. Wasay M, Khatri IA, Khealani B, Sheerani M (2006) MS in Asian countries. Int MS J 13:58–65

    PubMed  CAS  Google Scholar 

  42. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Neurology, Ullevål University Hospital, 0407, Oslo, Norway

    C. Smestad, T. Holmoy, H. F. Harbo & E. G. Celius

  2. Center for Clinical Research, Ullevål University Hospital, Oslo, Norway

    L. Sandvik

  3. Institute of Immunology, Faculty Division Rikshospitalet, University of Oslo, Norway

    T. Holmoy & H. F. Harbo

Authors
  1. C. Smestad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Sandvik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Holmoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. F. Harbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. G. Celius
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Smestad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smestad, C., Sandvik, L., Holmoy, T. et al. Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol 255, 49–55 (2008). https://doi.org/10.1007/s00415-007-0659-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-0659-8

Key words

Search

Navigation